Leen Heyens; Dana Busschots; Ger H. Koek; Geert Robaeys; Sven Francque · 2021 · Frontiers in Medicine
Paper
An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis to non-alcoholic steatohepatitis (NASH). NASH is a chronic state of liver inflammation that leads to the transformation of hepatic stellate cells to myofibroblasts. These cells produce extra-cellular matrix that results in liver fibrosis. In a normal situation, fibrogenesis is a wound healing process that preserves tissue integrity. However, sustained and progressive fibrosis can become pathogenic. This process takes many years and is often asymptomatic. Therefore, patients usually present themselves with end-stage liver disease e.g., liver cirrhosis, decompensated liver disease or even hepatocellular carcinoma. Fibrosis has also been identified as the most important predictor of prognosis in patients with NAFLD. Currently, only a minority of patients with liver fibrosis are identified to be at risk and hence referred for treatment. This is not only because the disease is largely asymptomatic, but also due to the fact that currently liver biopsy is still the golden standard for accurate detection of liver fibrosis. However, performing a liver biopsy harbors some risks and requires resources and expertise, hence is not applicable in every clinical setting and is unsuitable for screening. Consequently, different non-invasive diagnostic tools, mainly based on analysis of blood or other specimens or based on imaging have been developed or are in development. In this review, we will first give an overview of the pathogenic mechanisms of the evolution from isolated steatosis to fibrosis. This serves as the basis for the subsequent discussion of the current and future diagnostic biomarkers and anti-fibrotic drugs.
Analysis
This review discusses the progression of liver fibrosis in NAFLD, highlighting the limitations of liver biopsy and exploring the development and potential of non-invasive biomarkers and anti-fibrotic therapies for improved diagnosis and treatment.
Discovery
Hyukjung Kwon; Sun Hye Shin; Hyun Ho Kim; Na Young Min; Yugyeong Lim; T. Joo; Kyoung Joo Lee; Minseon Jeong; Hyojung Kim; Seon-young Yun; Yoon-Hee Kim; Dabin Park; Joungsu Joo; Jin‐Sik Bae; Sunghoon Lee; Byeong‐Ho Jeong; Kyungjong Lee; Hayemin Lee; Hong Kwan Kim; Kyongchol Kim; Sang‐Won Um; Changhyeok An; Min Seob Lee
Christopher Abbosh; Alexander M. Frankell; Thomas Harrison; Judit Kisistók; Aaron T. Garnett; Laura Johnson; Selvaraju Veeriah; Mike Moreau; Adrian Chesh; Tafadzwa L. Chaunzwa; Jakob Weiss; Morgan R. Schroeder; Sophia Ward; Kristiana Grigoriadis; Aamir Shahpurwalla; Kevin Litchfield; Clare Puttick; Dhruva Biswas; Takahiro Karasaki; James R. Black; Carlos Martínez‐Ruiz; Maise Al Bakir; Oriol Pich; Thomas B.K. Watkins; Emilia L. Lim; Ariana Huebner; David A. Moore; Nadia Godin-Heymann; Anne L’Hernault; Hannah Bye; Aaron Odell; Paula Kalavakur; Fábio Gomes; Akshay J. Patel; Elizabeth Manzano; Crispin T. Hiley; Nicolas Carey; Joan Riley; Daniel E. Cook; Darren Hodgson; Daniel Stetson; J. Carl Barrett; Roderik M. Kortlever; Gérard I. Evan; Allan Hackshaw; Robert Daber; Jacqui Shaw; Hugo J.W.L. Aerts; Abel Licon; Josh Stahl; Mariam Jamal‐Hanjani; J.F. Lester; Amrita Bajaj; Apostolos Nakas; Azmina Sodha-Ramdeen; Keng Ang; Mohamad Tufail; Mohammed Fiyaz Chowdhry; Molly Scotland; Rebecca Boyles; Sridhar Rathinam; Claire Wilson; Domenic Marrone; Sean Dulloo; Dean A. Fennell; Gurdeep Matharu; Lindsay Primrose; Ekaterini Boleti; Heather Cheyne; Mohammed S. Khalil; Shirley Richardson; Tracey Cruickshank; Gillian Price; Keith M. Kerr; Sarah Benafif; Kayleigh Gilbert; Babu Naidu; Aya Osman; Christer Lacson; Gerald Langman; Helen Shackleford; Madava Djearaman; Salma Kadiri; Gary Middleton; Angela Leek; Jack Davies Hodgkinson; Nicola Totten; Ángeles Montero; Elaine Smith; Eustace Fontaine; Felice Granato; Helen Doran; Juliette Novasio; Kendadai Rammohan; Leena Dennis Joseph; Paul Bishop; Rajesh Shah; Stuart Moss; Vijay Joshi; Philip Crosbie
Siobhan Connal; James M. Cameron; Alexandra Sala; Paul M. Brennan; David Scott Palmer; Joshua D. Palmer; Haley K. Perlow; Matthew J. Baker
Giovanna Maria Stanfoca Casagrande; Marcela de Oliveira Silva; Rui Manuel Reis; Letícia Ferro Leal
Saife N. Lone; Sabah Nisar; Tariq Masoodi; Mayank Singh; Arshi Rizwan; Sheema Hashem; Wael El‐Rifai; Davide Bedognetti; Surinder K. Batra; Mohammad Haris; Ajaz A. Bhat; Muzafar A. Macha
David L. Crosby; Sangeeta N. Bhatia; Kevin M. Brindle; Lisa M. Coussens; Caroline Dive; Mark Emberton; Sadik C. Esener; Rebecca C. Fitzgerald; Sanjiv S. Gambhir; Peter Kühn; Timothy R. Rebbeck; Shankar Balasubramanian
Source record